Concord Drugs Board to Consider Q2 FY27 Financial Results on 12th Nov'26
Concord Drugs Ltd 路 Intimation 路 12 Nov 2026, 5:30 am
Concord Drugs Board to Consider Q2 FY27 Financial Results on 12th Nov'26 Concord Drugs Limited has scheduled a Board of Directors meeting on 12th Nov'26 to consider and approve the un-audited standalone and consolidated financial results for the quarter ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in the company's equity shares remains closed for designated persons and their immediate relatives until 48 hours following the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Concord Drugs Ltd
- Board has approved and considered financial results for quarter ending 30th Sep, 2026. 路 13 Nov 2026
- Board has Considered and approved quarterly results for 30th Sep,2026. 路 13 Nov 2026
- Annual general meeting -Scrutinizer''s Report 路 01 Oct 2026
- Summary Proceedings of AGM 路 01 Oct 2026
- Letter to members as per regulation 36(1)(b) 路 08 Sept 2026
- Record date for Annual general meeting 路 08 Sept 2026
- 31st Annual Report of the Company 路 08 Sept 2026
- AGM to be held on 30.09.2026 at 09:00 AM 路 08 Sept 2026
